Cyclacel pharmaceuticals announces stock split

Berkeley heights, n.j., july 02, 2025 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; “cyclacel” or the “company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a 1-for-15 reverse stock split on its shares of common stock effective july 7, 2025, with trading to begin on a split-adjusted basis at the market open on that day.
CYCC Ratings Summary
CYCC Quant Ranking